NOVEL ANTI-THYMIDINE KINASE ANTIBODIES

The present invention relates to a novel monoclonal antibody that specifically binds to a conformation dependent epitope on human thymidine kinase 1 (hTK-1; SEQ ID NO:1), to methods for quantifying hTK-1 employing the antibody and to the use of the anti-hTK-1 antibody in quantifying hTK-1.

Saved in:
Bibliographic Details
Main Authors Duefel, Hartmut, Engel, Alfred, Meier, Thomas, Rutz, Sandra, Schraeml, Michael, Kurtkaya, Ulrike, Zimmermann, Christina, Kroner, Frank, Tabares, Gloria, Pinchuk, Boris
Format Patent
LanguageEnglish
Published 04.03.2021
Subjects
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a novel monoclonal antibody that specifically binds to a conformation dependent epitope on human thymidine kinase 1 (hTK-1; SEQ ID NO:1), to methods for quantifying hTK-1 employing the antibody and to the use of the anti-hTK-1 antibody in quantifying hTK-1.
Bibliography:Application Number: US202017069349